Onicor Appoints Piet De Doncker as Chief Executive Officer
PRIVATEOct 21, 2026
Position
Chief Executive Officer
Company
Onicor
Piet De Doncker
North BrabantBiotechnologyHealth CareMedicalMedical Device
Description
Onicor has appointed Piet De Doncker, PhD, as its new Chief Executive Officer, succeeding Ronald van der Geest, PhD. With over three decades of experience in antifungal drug development, Dr. De Doncker aims to lead the company's innovative treatment solutions for onychomycosis.
Who to call at Onicor, and when
A new leader at Onicor brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Onicor raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Onicor, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Onicor
Location
North Brabant, Netherlands
About
Onicor is a medical technology company that specializes in developing personalized treatments for onychomycosis, a difficult fungal nail infection. The company is pioneering solutions that combine medical device engineering with clinical expertise to improve treatment efficacy. Onicor operates under an ISO 13485-certified quality management system, ensuring high standards in its product development. The company collaborates with industry and academic partners to advance its innovative approaches.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Onicor changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.